Literature DB >> 2479597

Angiographically undetected small hepatocellular carcinoma: clinicopathological characteristics, follow-up and treatment.

T Sonoda1, K Shirabe, K Takenaka, T Kanematsu, K Yasumori, K Sugimachi.   

Abstract

We studied 36 cases (38 nodules) of small hepatocellular carcinoma with special attention directed to detectability using angiography and histology. Among the 38 nodules, 31 nodules (81.6%) were evident. The remaining seven (18.4%) were not evident angiographically but were detected using ultrasonography and/or computed tomography, prior to angiography. An elevated level of serum alpha-fetoprotein also suggested a diagnosis of hepatocellular carcinoma. When comparisons were made between angiographically detected and undetected nodules, there was no statistically significant difference in parameters, including sex of the patient, tumor size, location of the tumor, positive rate for hepatitis B surface antigen, history of liver disease and values of alpha-fetoprotein. The small hepatocellular carcinomas not detected angiographically and evidenced only histologically had the following characteristics: (i) no fibrous capsule surrounding the nodules; (ii) well-differentiated tumors; (iii) replacing growth pattern of cancer cells, and (iv) remains of portal tracts within the tumor. The replacing growth pattern and the presence of portal tracts may correlate with the low detectability in angiography. When a definite diagnosis of angiographically undetectable tumors cannot be made using close surveillance with ultrasonography or alpha-fetoprotein and/or needle biopsy under ultrasonic guide, surgical intervention should be considered, particularly for patients at high risk for hepatocellular carcinoma.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2479597     DOI: 10.1002/hep.1840100619

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  6 in total

1.  A network-based maximum link approach towards MS identifies potentially important roles for undetected ARRB1/2 and ACTB in liver cancer progression.

Authors:  Wilson Wen Bin Goh; Yie Hou Lee; Zubaidah M Ramdzan; Maxey C M Chung; Limsoon Wong; Marek J Sergot
Journal:  Int J Bioinform Res Appl       Date:  2012

2.  Radiologically identifiable intratumoral portal vein in intrahepatic cholangiomas: a diagnostic pitfall.

Authors:  K Kaneko; H Honda; K Kajiyama; Y Yokomizo; N Hashiguchi; T Fukuya; Y Tateshi; T Ro; K Masuda
Journal:  Abdom Imaging       Date:  1996 Sep-Oct

3.  Angiopoietin switching regulates angiogenesis and progression of human hepatocellular carcinoma.

Authors:  K Sugimachi; S Tanaka; K Taguchi; S Aishima; M Shimada; M Tsuneyoshi
Journal:  J Clin Pathol       Date:  2003-11       Impact factor: 3.411

4.  Relationship of the microvascular type to the tumor size, arterialization and dedifferentiation of human hepatocellular carcinoma.

Authors:  T Yamamoto; K Hirohashi; K Kaneda; T Ikebe; S Mikami; T Uenishi; A Kanazawa; S Takemura; T Shuto; H Tanaka; S Kubo; M Sakurai; H Kinoshita
Journal:  Jpn J Cancer Res       Date:  2001-11

5.  Suppressive effect of the angiogenesis inhibitor TNP-470 on the development of carcinogen-induced hepatic nodules in rats.

Authors:  T Ikebe; T Yamamoto; S Kubo; K Hirohashi; H Kinoshita; K Kaneda; M Sakurai
Journal:  Jpn J Cancer Res       Date:  1998-02

6.  Sinusoidal capillarization and arterial blood supply continuously proceed with the advance of the stages of hepatocarcinogenesis in the rat.

Authors:  T Yamamoto; K Kaneda; K Hirohashi; H Kinoshita; M Sakurai
Journal:  Jpn J Cancer Res       Date:  1996-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.